Telos Rx review

Telos Rx has a broad current catalog spanning compounded GLP-1 treatment, a lower-dose tirzepatide option, oral preparations and a separate women's hormone listing. It also names pharmacy partners and describes quarterly labs on treatment pages. The breadth is appealing, but the legal terms disagree with some of the simpler all-inclusive and cancel-anytime language.

A woman considering Telos should obtain a written plan for the exact medication, commitment and testing before comparing its lowest headline with another clinic. This review assesses the public offer rather than patient treatment or customer-service performance.

The advertised prices are starting points

The tirzepatide injection page currently advertises as low as $139 per month, with a $399 reference figure. It says the price depends on plan length, but the extracted public page does not display a complete payment ladder establishing the flexible monthly charge and all prepaid totals. The $139 figure should therefore remain a plan-dependent starting amount, not a verified month-to-month rate.

The oral GLP-1 page uses a from $9 per day headline, footnoted to a three-month prepaid oral semaglutide plan, even though the URL is oral-tirzepatide. That is an important mismatch for someone looking specifically for tirzepatide. Do not assume the daily amount buys either molecule, or convert it into a precise monthly subscription without the actual plan terms.

Older $49 and $129 oral promotions do not establish the current order's cost. The present website emphasizes an intake to determine pricing. Ask for the first charge, continuing amount, billing interval, supply quantity and full term. A familiar price from an earlier comparison may no longer describe the treatment being offered now.

The product pages say dose increases do not raise the price and advertise free shipping, consultation and unlimited care-team messaging. They also describe quarterly labs as included. The legal terms, however, state that laboratory testing is not included in the Rx product price. Obtain a written answer for your selected plan before budgeting on either claim.

Who provides care and medication?

Telos identifies itself as a technology and administrative platform connecting patients with independent clinical groups. The terms name Arora Health Group among affiliated clinical entities. Clinical decisions and prescribing belong to the licensed provider, rather than the platform or an automated intake result.

The current treatment FAQ names VialsRX and F&F Pharmacies Inc., doing business as Jungle Jim's Pharmacy, as fulfillment partners. It also describes restrictions on the latter pharmacy's state licenses and sterile dispensing. That explains why an overall national-service claim cannot guarantee that each pharmacy can fill every formulation in every location.

The website says services are available across all fifty states through its medical and pharmacy network, while specific medication choices and fulfillment vary by location. Ask which pharmacy will dispense the prescription at your address, and request the actual ingredients, concentration and instructions. A product image or a brand-like label is not the dispensing label.

The supplied GLP-1 preparations are compounded and not FDA-approved. Telos' oral products are described as daily sublingual formulations rather than approved manufacturer tablets. Similar receptor mechanisms do not establish equivalent absorption or clinical outcomes for different routes. Our compounded versus brand-name guide can help frame that distinction.

Women's hormones and lower-dose marketing

The homepage lists estradiol plus progesterone for perimenopause and menopause, with patch, gel or oral estradiol and micronized progesterone when indicated. That is more specific than a generic testosterone menu. It still does not establish that women's hormone treatment is included with a GLP-1 purchase or that one clinician will manage both.

If coordinated HRT is a priority, ask whether the women's service is currently accepting patients in your state, which approved or compounded preparations it uses and whether records are shared with your weight prescriber. Our GLP-1 and HRT guide can help prepare the questions without treating hormone therapy as a weight-loss treatment.

The site also markets microdosed tirzepatide to people with lower BMI for metabolic goals. A lower-dose menu does not establish an approved indication or prove benefits for energy, body composition or menopause symptoms. Discuss the clinical reason, alternatives and monitoring with the prescriber rather than interpret a broad eligibility claim as a recommendation for every woman.

A number of outcome figures on the GLP-1 pages are explicitly labeled illustrative and not patient outcome data. They should not be read as independently measured Telos results. Testimonials also do not establish the average response or the quality of a specific clinician's care.

Cancellation and prepaid commitments

The shipping policy says charges become final and non-refundable once a prescription is approved and sent to the pharmacy, including medication and consultation or program fees. That is earlier than delivery. The one-click cancellation language on treatment pages mainly concerns future cycles, rather than an unconditional refund of the current order.

The terms additionally describe multi-month commitments, so a discounted monthly equivalent should not be assumed to permit leaving after one month without financial consequences. Ask how unfulfilled supplies, clinical discontinuation and remaining prepaid money are treated. A plan-dependent starting price is only comparable after these conditions are clear.

The website advertises free two-day priority shipping after fulfillment, with temperature-controlled discreet packaging. A pharmacy's preparation and the carrier's journey are separate stages. Report a quality concern such as a leaking vial or missing component within forty-eight hours of delivery, according to the policy, and retain the product and packaging for review.

Telos is a relevant comparison for women wanting several treatment routes and a visible HRT listing. Its limitations are incomplete public price totals, conflicting lab-cost language and the commitment behind simple cancellation claims. Our provider-selection guide can help turn that broad catalog into a concrete, comparable offer before payment.